Granules India Q1FY22 consolidated net profit at Rs. 120.20 Cr
The company posted net profit of Rs.111.44 crores for the period ended June 30, 2020.
The company posted net profit of Rs.111.44 crores for the period ended June 30, 2020.
ADG20, a novel monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses
As of 2025, the new Translational Science Center will offer room for more than 500 scientists, who will conduct research in a wide variety of fields ranging from the identification of disease biomarkers to the development of targeted therapies
Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL is AN-rated generic therapeutic equivalent version of Sunovion Pharmaceuticals Inc.’s Brovana
Bayer Zydus Pharma will continue to operate in core therapies with new products in the pipeline
EPL will supply APR approved 100% recyclable and fully sustainable Platina Tubes for the toothpaste category of Unilever
US revenues were sequentially stable at US$370mn with steady performance in the specialty portfolio
The company is pursuing specific goals in the areas of science and technology, value chain as well as climate and the environment.
TCPCL is the largest and only commercial manufacturer of SDAs for zeolites in India
Has signed a 12-year, off-site, virtual power purchase agreement (VPPA) with Enel Green Power
Subscribe To Our Newsletter & Stay Updated